CCR4 and neoplasm: Thus, we hypothesized that CCR4‐expressing CD39+ Tregs in peripheral blood could be chemotactically attracted to the tumour microenvironment to exert immunosuppressive effects, leading to immunotherapy resistance and a worse prognosis in our study.